JPWO2020146906A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020146906A5 JPWO2020146906A5 JP2021540420A JP2021540420A JPWO2020146906A5 JP WO2020146906 A5 JPWO2020146906 A5 JP WO2020146906A5 JP 2021540420 A JP2021540420 A JP 2021540420A JP 2021540420 A JP2021540420 A JP 2021540420A JP WO2020146906 A5 JPWO2020146906 A5 JP WO2020146906A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- mage
- abl
- gage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000004027 cell Anatomy 0.000 claims description 5
- 210000004881 tumor cell Anatomy 0.000 claims description 2
- -1 carrier Substances 0.000 claims 12
- 108090000765 processed proteins & peptides Proteins 0.000 claims 9
- 230000001225 therapeutic effect Effects 0.000 claims 9
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims 7
- 241001465754 Metazoa Species 0.000 claims 7
- 206010028980 Neoplasm Diseases 0.000 claims 6
- 239000003446 ligand Substances 0.000 claims 6
- 238000000034 method Methods 0.000 claims 6
- 208000024891 symptom Diseases 0.000 claims 6
- 201000011510 cancer Diseases 0.000 claims 5
- 230000002209 hydrophobic effect Effects 0.000 claims 5
- 210000004962 mammalian cell Anatomy 0.000 claims 5
- 241000124008 Mammalia Species 0.000 claims 4
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 208000015181 infectious disease Diseases 0.000 claims 4
- 239000002105 nanoparticle Substances 0.000 claims 4
- 108010051109 Cell-Penetrating Peptides Proteins 0.000 claims 3
- 102000020313 Cell-Penetrating Peptides Human genes 0.000 claims 3
- 102100021533 Kita-kyushu lung cancer antigen 1 Human genes 0.000 claims 3
- 239000000427 antigen Substances 0.000 claims 3
- 108091007433 antigens Proteins 0.000 claims 3
- 102000036639 antigens Human genes 0.000 claims 3
- 239000002246 antineoplastic agent Substances 0.000 claims 3
- 125000002091 cationic group Chemical group 0.000 claims 3
- 239000003795 chemical substances by application Substances 0.000 claims 3
- 229940127089 cytotoxic agent Drugs 0.000 claims 3
- 210000004443 dendritic cell Anatomy 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 208000014674 injury Diseases 0.000 claims 3
- 210000000056 organ Anatomy 0.000 claims 3
- 230000002265 prevention Effects 0.000 claims 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 2
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims 2
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims 2
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 claims 2
- 102100040578 G antigen 7 Human genes 0.000 claims 2
- 241000282412 Homo Species 0.000 claims 2
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims 2
- 101000893968 Homo sapiens G antigen 7 Proteins 0.000 claims 2
- 101000971605 Homo sapiens Kita-kyushu lung cancer antigen 1 Proteins 0.000 claims 2
- 101001057156 Homo sapiens Melanoma-associated antigen C2 Proteins 0.000 claims 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims 2
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims 2
- 102100027252 Melanoma-associated antigen C2 Human genes 0.000 claims 2
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000000890 antigenic effect Effects 0.000 claims 2
- 239000000872 buffer Substances 0.000 claims 2
- 239000003085 diluting agent Substances 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 230000004064 dysfunction Effects 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 108010044720 telomerase reverse transcriptase (540-548) Proteins 0.000 claims 2
- 230000008733 trauma Effects 0.000 claims 2
- 239000003981 vehicle Substances 0.000 claims 2
- SSOORFWOBGFTHL-OTEJMHTDSA-N (4S)-5-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[2-[(2S)-2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1-[[(2S)-5-amino-1-[[(2S)-5-carbamimidamido-1-[[(2S)-5-carbamimidamido-1-[[(1S)-4-carbamimidamido-1-carboxybutyl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]carbamoyl]pyrrolidin-1-yl]-2-oxoethyl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-imidazol-4-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2,6-diaminohexanoyl]amino]-3-methylbutanoyl]amino]propanoyl]amino]-5-oxopentanoic acid Chemical compound CC[C@H](C)[C@H](NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H](N)CCCCN)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SSOORFWOBGFTHL-OTEJMHTDSA-N 0.000 claims 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 1
- AOJJSUZBOXZQNB-VTZDEGQISA-N 4'-epidoxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-VTZDEGQISA-N 0.000 claims 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims 1
- 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 claims 1
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims 1
- 102000052587 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Human genes 0.000 claims 1
- 108700004606 Anaphase-Promoting Complex-Cyclosome Apc3 Subunit Proteins 0.000 claims 1
- 102000004149 Annexin A2 Human genes 0.000 claims 1
- 108090000668 Annexin A2 Proteins 0.000 claims 1
- 101100288313 Arabidopsis thaliana KTI4 gene Proteins 0.000 claims 1
- 101000719121 Arabidopsis thaliana Protein MEI2-like 1 Proteins 0.000 claims 1
- 102100035526 B melanoma antigen 1 Human genes 0.000 claims 1
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims 1
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims 1
- 102100021663 Baculoviral IAP repeat-containing protein 5 Human genes 0.000 claims 1
- 101000653197 Beet necrotic yellow vein virus (isolate Japan/S) Movement protein TGB3 Proteins 0.000 claims 1
- 241000219198 Brassica Species 0.000 claims 1
- 235000003351 Brassica cretica Nutrition 0.000 claims 1
- 235000003343 Brassica rupestris Nutrition 0.000 claims 1
- 101150108242 CDC27 gene Proteins 0.000 claims 1
- 101150034344 CT83 gene Proteins 0.000 claims 1
- 101100005789 Caenorhabditis elegans cdk-4 gene Proteins 0.000 claims 1
- 241000282836 Camelus dromedarius Species 0.000 claims 1
- KLWPJMFMVPTNCC-UHFFFAOYSA-N Camptothecin Natural products CCC1(O)C(=O)OCC2=C1C=C3C4Nc5ccccc5C=C4CN3C2=O KLWPJMFMVPTNCC-UHFFFAOYSA-N 0.000 claims 1
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 claims 1
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims 1
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims 1
- DLGOEMSEDOSKAD-UHFFFAOYSA-N Carmustine Chemical compound ClCCNC(=O)N(N=O)CCCl DLGOEMSEDOSKAD-UHFFFAOYSA-N 0.000 claims 1
- 102100026548 Caspase-8 Human genes 0.000 claims 1
- 108090000538 Caspase-8 Proteins 0.000 claims 1
- 102000053642 Catalytic RNA Human genes 0.000 claims 1
- 108090000994 Catalytic RNA Proteins 0.000 claims 1
- 101000905202 Clostridium botulinum C phage Main hemagglutinin component type C Proteins 0.000 claims 1
- 101000905190 Clostridium botulinum D phage Main hemagglutinin component type D Proteins 0.000 claims 1
- 108050006400 Cyclin Proteins 0.000 claims 1
- 102000016736 Cyclin Human genes 0.000 claims 1
- 102100024462 Cyclin-dependent kinase 4 inhibitor B Human genes 0.000 claims 1
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 claims 1
- 108020004414 DNA Proteins 0.000 claims 1
- 102100040606 Dermatan-sulfate epimerase Human genes 0.000 claims 1
- 101710127030 Dermatan-sulfate epimerase Proteins 0.000 claims 1
- 101100216227 Dictyostelium discoideum anapc3 gene Proteins 0.000 claims 1
- 101150029707 ERBB2 gene Proteins 0.000 claims 1
- 102100035078 ETS-related transcription factor Elf-2 Human genes 0.000 claims 1
- HTIJFSOGRVMCQR-UHFFFAOYSA-N Epirubicin Natural products COc1cccc2C(=O)c3c(O)c4CC(O)(CC(OC5CC(N)C(=O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO HTIJFSOGRVMCQR-UHFFFAOYSA-N 0.000 claims 1
- 102100028075 Fibroblast growth factor 6 Human genes 0.000 claims 1
- 108090000382 Fibroblast growth factor 6 Proteins 0.000 claims 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 claims 1
- 102100039699 G antigen 4 Human genes 0.000 claims 1
- 102100039698 G antigen 5 Human genes 0.000 claims 1
- 101710092267 G antigen 5 Proteins 0.000 claims 1
- 102100039713 G antigen 6 Human genes 0.000 claims 1
- 101710092269 G antigen 6 Proteins 0.000 claims 1
- 108010012015 GVYDGREHTV Proteins 0.000 claims 1
- 102000010956 Glypican Human genes 0.000 claims 1
- 108050001154 Glypican Proteins 0.000 claims 1
- 108050007237 Glypican-3 Proteins 0.000 claims 1
- 102100028721 Hermansky-Pudlak syndrome 5 protein Human genes 0.000 claims 1
- 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 claims 1
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims 1
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims 1
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims 1
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 claims 1
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims 1
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 claims 1
- 101000980919 Homo sapiens Cyclin-dependent kinase 4 inhibitor B Proteins 0.000 claims 1
- 101000954709 Homo sapiens Doublecortin domain-containing protein 2 Proteins 0.000 claims 1
- 101000877377 Homo sapiens ETS-related transcription factor Elf-2 Proteins 0.000 claims 1
- 101000886678 Homo sapiens G antigen 2D Proteins 0.000 claims 1
- 101000886136 Homo sapiens G antigen 4 Proteins 0.000 claims 1
- 101000985516 Homo sapiens Hermansky-Pudlak syndrome 5 protein Proteins 0.000 claims 1
- 101000614481 Homo sapiens Kidney-associated antigen 1 Proteins 0.000 claims 1
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 claims 1
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 claims 1
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims 1
- 101001133081 Homo sapiens Mucin-2 Proteins 0.000 claims 1
- 101000721712 Homo sapiens NTF2-related export protein 1 Proteins 0.000 claims 1
- 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 claims 1
- 101001109419 Homo sapiens RNA-binding protein NOB1 Proteins 0.000 claims 1
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 claims 1
- 101000665137 Homo sapiens Scm-like with four MBT domains protein 1 Proteins 0.000 claims 1
- 101000648075 Homo sapiens Trafficking protein particle complex subunit 1 Proteins 0.000 claims 1
- 101000813738 Homo sapiens Transcription factor ETV6 Proteins 0.000 claims 1
- 101100540311 Human papillomavirus type 16 E6 gene Proteins 0.000 claims 1
- 101000767631 Human papillomavirus type 16 Protein E7 Proteins 0.000 claims 1
- 101710123134 Ice-binding protein Proteins 0.000 claims 1
- 101710082837 Ice-structuring protein Proteins 0.000 claims 1
- 102100026720 Interferon beta Human genes 0.000 claims 1
- 108010047761 Interferon-alpha Proteins 0.000 claims 1
- 102000006992 Interferon-alpha Human genes 0.000 claims 1
- 108090000467 Interferon-beta Proteins 0.000 claims 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 claims 1
- 239000002136 L01XE07 - Lapatinib Substances 0.000 claims 1
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 claims 1
- 108010059255 MAGE-A10 antigen Proteins 0.000 claims 1
- 108010010995 MART-1 Antigen Proteins 0.000 claims 1
- 102000043129 MHC class I family Human genes 0.000 claims 1
- 108091054437 MHC class I family Proteins 0.000 claims 1
- 102000043131 MHC class II family Human genes 0.000 claims 1
- 108091054438 MHC class II family Proteins 0.000 claims 1
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 claims 1
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims 1
- 102100034256 Mucin-1 Human genes 0.000 claims 1
- 102100034263 Mucin-2 Human genes 0.000 claims 1
- 101001062862 Mus musculus Fatty acid-binding protein, adipocyte Proteins 0.000 claims 1
- 102000003505 Myosin Human genes 0.000 claims 1
- 108060008487 Myosin Proteins 0.000 claims 1
- ZDZOTLJHXYCWBA-VCVYQWHSSA-N N-debenzoyl-N-(tert-butoxycarbonyl)-10-deacetyltaxol Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)C=4C=CC=CC=4)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 ZDZOTLJHXYCWBA-VCVYQWHSSA-N 0.000 claims 1
- 102000036673 PRAME Human genes 0.000 claims 1
- 108060006580 PRAME Proteins 0.000 claims 1
- 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 claims 1
- 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 claims 1
- 229930012538 Paclitaxel Natural products 0.000 claims 1
- 101000621505 Peanut clump virus (isolate 87/TGTA2) Suppressor of RNA silencing Proteins 0.000 claims 1
- 108010033276 Peptide Fragments Proteins 0.000 claims 1
- 102000007079 Peptide Fragments Human genes 0.000 claims 1
- 102100021768 Phosphoserine aminotransferase Human genes 0.000 claims 1
- 102100022019 Pregnancy-specific beta-1-glycoprotein 2 Human genes 0.000 claims 1
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims 1
- 108010081208 RMFPNAPYL Proteins 0.000 claims 1
- 102100022491 RNA-binding protein NOB1 Human genes 0.000 claims 1
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 claims 1
- 102100031770 SH2B adapter protein 1 Human genes 0.000 claims 1
- 108050003189 SH2B adapter protein 1 Proteins 0.000 claims 1
- 102100038689 Scm-like with four MBT domains protein 1 Human genes 0.000 claims 1
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 claims 1
- 108020004459 Small interfering RNA Proteins 0.000 claims 1
- 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 claims 1
- 101710185775 Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 claims 1
- 108010002687 Survivin Proteins 0.000 claims 1
- 108010032166 TARP Proteins 0.000 claims 1
- 101150033985 TPI gene Proteins 0.000 claims 1
- 101150032817 TPI1 gene Proteins 0.000 claims 1
- 108020000411 Toll-like receptor Proteins 0.000 claims 1
- 102100025256 Trafficking protein particle complex subunit 1 Human genes 0.000 claims 1
- 102100039580 Transcription factor ETV6 Human genes 0.000 claims 1
- 108700015934 Triose-phosphate isomerases Proteins 0.000 claims 1
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 claims 1
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims 1
- 102000003425 Tyrosinase Human genes 0.000 claims 1
- 108060008724 Tyrosinase Proteins 0.000 claims 1
- 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 claims 1
- 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 claims 1
- JXLYSJRDGCGARV-WWYNWVTFSA-N Vinblastine Natural products O=C(O[C@H]1[C@](O)(C(=O)OC)[C@@H]2N(C)c3c(cc(c(OC)c3)[C@]3(C(=O)OC)c4[nH]c5c(c4CCN4C[C@](O)(CC)C[C@H](C3)C4)cccc5)[C@@]32[C@H]2[C@@]1(CC)C=CCN2CC3)C JXLYSJRDGCGARV-WWYNWVTFSA-N 0.000 claims 1
- 102000040856 WT1 Human genes 0.000 claims 1
- 108700020467 WT1 Proteins 0.000 claims 1
- 101150084041 WT1 gene Proteins 0.000 claims 1
- 208000027418 Wounds and injury Diseases 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 229960005475 antiinfective agent Drugs 0.000 claims 1
- 239000003524 antilipemic agent Substances 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- QKSKPIVNLNLAAV-UHFFFAOYSA-N bis(2-chloroethyl) sulfide Chemical compound ClCCSCCCl QKSKPIVNLNLAAV-UHFFFAOYSA-N 0.000 claims 1
- VSJKWCGYPAHWDS-FQEVSTJZSA-N camptothecin Chemical compound C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)[C@]5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-FQEVSTJZSA-N 0.000 claims 1
- 229940127093 camptothecin Drugs 0.000 claims 1
- 229960004117 capecitabine Drugs 0.000 claims 1
- 229960004562 carboplatin Drugs 0.000 claims 1
- 190000008236 carboplatin Chemical compound 0.000 claims 1
- 229960005243 carmustine Drugs 0.000 claims 1
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 1
- 229960004316 cisplatin Drugs 0.000 claims 1
- 229960004397 cyclophosphamide Drugs 0.000 claims 1
- 230000006378 damage Effects 0.000 claims 1
- 230000007547 defect Effects 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- VSJKWCGYPAHWDS-UHFFFAOYSA-N dl-camptothecin Natural products C1=CC=C2C=C(CN3C4=CC5=C(C3=O)COC(=O)C5(O)CC)C4=NC2=C1 VSJKWCGYPAHWDS-UHFFFAOYSA-N 0.000 claims 1
- 229960003668 docetaxel Drugs 0.000 claims 1
- 229960004679 doxorubicin Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229960001904 epirubicin Drugs 0.000 claims 1
- UFNVPOGXISZXJD-XJPMSQCNSA-N eribulin Chemical compound C([C@H]1CC[C@@H]2O[C@@H]3[C@H]4O[C@H]5C[C@](O[C@H]4[C@H]2O1)(O[C@@H]53)CC[C@@H]1O[C@H](C(C1)=C)CC1)C(=O)C[C@@H]2[C@@H](OC)[C@@H](C[C@H](O)CN)O[C@H]2C[C@@H]2C(=C)[C@H](C)C[C@H]1O2 UFNVPOGXISZXJD-XJPMSQCNSA-N 0.000 claims 1
- 229960003649 eribulin Drugs 0.000 claims 1
- VJJPUSNTGOMMGY-MRVIYFEKSA-N etoposide Chemical compound COC1=C(O)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@@H](O[C@H]3[C@@H]([C@@H](O)[C@@H]4O[C@H](C)OC[C@H]4O3)O)[C@@H]3[C@@H]2C(OC3)=O)=C1 VJJPUSNTGOMMGY-MRVIYFEKSA-N 0.000 claims 1
- 229960005420 etoposide Drugs 0.000 claims 1
- 229960002949 fluorouracil Drugs 0.000 claims 1
- 239000012634 fragment Substances 0.000 claims 1
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 1
- 229960005277 gemcitabine Drugs 0.000 claims 1
- 108010014242 gp100(17-25) peptide Proteins 0.000 claims 1
- 108010072094 gp100(280-288) melanoma antigen peptide Proteins 0.000 claims 1
- 239000005556 hormone Substances 0.000 claims 1
- 229940088597 hormone Drugs 0.000 claims 1
- 230000002519 immonomodulatory effect Effects 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- BCFGMOOMADDAQU-UHFFFAOYSA-N lapatinib Chemical compound O1C(CNCCS(=O)(=O)C)=CC=C1C1=CC=C(N=CN=C2NC=3C=C(Cl)C(OCC=4C=C(F)C=CC=4)=CC=3)C2=C1 BCFGMOOMADDAQU-UHFFFAOYSA-N 0.000 claims 1
- 229960004891 lapatinib Drugs 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 244000144972 livestock Species 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 230000001394 metastastic effect Effects 0.000 claims 1
- 206010061289 metastatic neoplasm Diseases 0.000 claims 1
- 229960000485 methotrexate Drugs 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- KKZJGLLVHKMTCM-UHFFFAOYSA-N mitoxantrone Chemical compound O=C1C2=C(O)C=CC(O)=C2C(=O)C2=C1C(NCCNCCO)=CC=C2NCCNCCO KKZJGLLVHKMTCM-UHFFFAOYSA-N 0.000 claims 1
- 229960001156 mitoxantrone Drugs 0.000 claims 1
- 235000010460 mustard Nutrition 0.000 claims 1
- OHDXDNUPVVYWOV-UHFFFAOYSA-N n-methyl-1-(2-naphthalen-1-ylsulfanylphenyl)methanamine Chemical compound CNCC1=CC=CC=C1SC1=CC=CC2=CC=CC=C12 OHDXDNUPVVYWOV-UHFFFAOYSA-N 0.000 claims 1
- 230000001613 neoplastic effect Effects 0.000 claims 1
- 230000007935 neutral effect Effects 0.000 claims 1
- 239000002353 niosome Substances 0.000 claims 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 1
- 229960001592 paclitaxel Drugs 0.000 claims 1
- 108010038982 peptide F4.2 Proteins 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 150000003904 phospholipids Chemical class 0.000 claims 1
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims 1
- 229940115272 polyinosinic:polycytidylic acid Drugs 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 239000000018 receptor agonist Substances 0.000 claims 1
- 229940044601 receptor agonist Drugs 0.000 claims 1
- 239000002464 receptor antagonist Substances 0.000 claims 1
- 229940044551 receptor antagonist Drugs 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 208000016691 refractory malignant neoplasm Diseases 0.000 claims 1
- 108091092562 ribozyme Proteins 0.000 claims 1
- 102200006539 rs121913529 Human genes 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 238000007910 systemic administration Methods 0.000 claims 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 claims 1
- 229960000575 trastuzumab Drugs 0.000 claims 1
- 229960003048 vinblastine Drugs 0.000 claims 1
- JXLYSJRDGCGARV-XQKSVPLYSA-N vincaleukoblastine Chemical compound C([C@@H](C[C@]1(C(=O)OC)C=2C(=CC3=C([C@]45[C@H]([C@@]([C@H](OC(C)=O)[C@]6(CC)C=CCN([C@H]56)CC4)(O)C(=O)OC)N3C)C=2)OC)C[C@@](C2)(O)CC)N2CCC2=C1NC1=CC=CC=C21 JXLYSJRDGCGARV-XQKSVPLYSA-N 0.000 claims 1
- GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 claims 1
- 229960002066 vinorelbine Drugs 0.000 claims 1
- 229960005486 vaccine Drugs 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- 238000002659 cell therapy Methods 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 238000002648 combination therapy Methods 0.000 description 1
- 238000011577 humanized mouse model Methods 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962791795P | 2019-01-12 | 2019-01-12 | |
| US62/791,795 | 2019-01-12 | ||
| PCT/US2020/013417 WO2020146906A2 (fr) | 2019-01-12 | 2020-01-13 | Nanoparticule peptidique auto-assemblée et utilisation associée |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022517236A JP2022517236A (ja) | 2022-03-07 |
| JPWO2020146906A5 true JPWO2020146906A5 (fr) | 2024-01-19 |
Family
ID=69771021
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021540420A Pending JP2022517236A (ja) | 2019-01-12 | 2020-01-13 | 自己組織化ペプチドナノ粒子およびその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220088221A1 (fr) |
| EP (1) | EP3908312A2 (fr) |
| JP (1) | JP2022517236A (fr) |
| CN (1) | CN113557035A (fr) |
| AU (1) | AU2020207087A1 (fr) |
| CA (1) | CA3126544A1 (fr) |
| WO (1) | WO2020146906A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112972424B (zh) * | 2021-03-19 | 2022-09-06 | 国家纳米科学中心 | 一种抗肿瘤多肽纳米药物及其制备方法和应用 |
| CN114404429B (zh) * | 2021-11-30 | 2023-06-30 | 重庆医科大学附属第二医院 | 一种纳米银修饰的单宁酸-铁网络的载药纳米复合物及其制备方法和逆转肿瘤耐药应用 |
| WO2023201370A2 (fr) * | 2022-04-15 | 2023-10-19 | University Of Florida Research Foundation, Incorporated | Granules peptidiques co-assemblées pour la distribution intracellulaire de protéines |
| WO2024006532A2 (fr) * | 2022-06-30 | 2024-01-04 | La Jolla Institute For Immunology | Nanoparticule de kari |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US5399363A (en) | 1991-01-25 | 1995-03-21 | Eastman Kodak Company | Surface modified anticancer nanoparticles |
| US5543158A (en) | 1993-07-23 | 1996-08-06 | Massachusetts Institute Of Technology | Biodegradable injectable nanoparticles |
| PT735893E (pt) | 1993-09-14 | 2009-03-06 | Pharmexa Inc | Péptidos que se ligam aos alelos pan dr para aumentar a resposta imunitária |
| IE80468B1 (en) | 1995-04-04 | 1998-07-29 | Elan Corp Plc | Controlled release biodegradable nanoparticles containing insulin |
| US20030077289A1 (en) | 2001-02-15 | 2003-04-24 | Rong-Fu Wang | Use of cell-penetrating peptides to generate antitumor immunity |
| CN101516404B (zh) * | 2006-03-30 | 2013-04-10 | 德莱斯医药公司 | 喜树碱-细胞渗透肽缀合物和含有其的药物组合物 |
| WO2009109428A2 (fr) | 2008-02-01 | 2009-09-11 | Alpha-O Peptides Ag | Nanoparticules peptidiques à auto-assemblage utiles comme vaccins |
| NZ704191A (en) * | 2010-06-14 | 2016-05-27 | Hoffmann La Roche | Cell-penetrating peptides and uses therof |
| ES2689799T3 (es) * | 2011-09-12 | 2018-11-15 | Pds Biotechnology Corporation | Formulaciones de vacunas particuladas |
| WO2014053880A1 (fr) | 2012-10-04 | 2014-04-10 | Centre National De La Recherche Scientifique | Peptides pénétrant dans les cellules pour l'administration intracellulaire de molécules |
| CN103965360A (zh) * | 2013-02-05 | 2014-08-06 | 杭州威星药业有限公司 | Ny-eso-1抗原及其在肿瘤免疫治疗中的应用 |
| EP2801370A1 (fr) * | 2013-05-07 | 2014-11-12 | Fundació Privada Institut d'Investigació Oncològica de Vall Hebron | Procédé et compositions de traitement du cancer |
| US20180133327A1 (en) * | 2015-03-16 | 2018-05-17 | Amal Therapeutics Sa | Cell Penetrating Peptides and Complexes Comprising the Same |
| CN108424437B (zh) * | 2018-02-08 | 2021-06-22 | 青岛农业大学 | 一种递送分子及纳米颗粒、制备方法、用途 |
-
2020
- 2020-01-13 CA CA3126544A patent/CA3126544A1/fr active Pending
- 2020-01-13 AU AU2020207087A patent/AU2020207087A1/en active Pending
- 2020-01-13 EP EP20709778.3A patent/EP3908312A2/fr active Pending
- 2020-01-13 CN CN202080020107.6A patent/CN113557035A/zh active Pending
- 2020-01-13 JP JP2021540420A patent/JP2022517236A/ja active Pending
- 2020-01-13 US US17/422,309 patent/US20220088221A1/en active Pending
- 2020-01-13 WO PCT/US2020/013417 patent/WO2020146906A2/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2416804B1 (fr) | Constituants thérapeutiques contenant de l'amatoxine de liaison à la surface cellulaire destinés à la thérapie des tumeurs | |
| AU667460B2 (en) | Targeted immunostimulation with bispecific reagents | |
| ES2558106T3 (es) | Formación de complejos de ácidos nucleicos con componentes catiónicos disulfuro-reticulados para la transfección e inmunoestimulación | |
| EP0932411B1 (fr) | Compositions contenant des molecules immunogenes et facteur de stimulation de colonie de granulocytes-macrophages en tant qu'adjuvant | |
| JP2012092097A (ja) | リガンド免疫原複合体を用いる処置方法 | |
| JP2022537151A (ja) | 癌の処置のためのネオアジュバント併用療法での活性化可能抗ｐｄｌ１抗体および抗ｃｔｌａ－４抗体の使用 | |
| US20200230236A1 (en) | Combination for t-cell immunotherapy and use thereof | |
| BR112020010937A2 (pt) | anticorpos anti-liv1 humanizados para o tratamento de câncer de mama | |
| EP3941511A2 (fr) | Utilisations d'amphiphiles en thérapie cellulaire immunitaire et compositions associées | |
| TW202118518A (zh) | 用於癌症、腫瘤及腫瘤細胞之局部及全身性治療之組合物及方法 | |
| CN107281488A (zh) | 对肿瘤疾病的治疗 | |
| AU2017201649B2 (en) | Xenoantigen-displaying anti-cancer vaccines and method of making | |
| JPWO2020146906A5 (fr) | ||
| WO2022182483A1 (fr) | Procédés de traitement local et systémique des cancers, des tumeurs et des cellules tumorales | |
| CN1856323B (zh) | 在癌症治疗中用于抑制多药耐药性的靶向p-糖蛋白170的治疗性疫苗 | |
| Meltzer et al. | Enhanced tumor growth in animals pretreated with complete Freund's adjuvant | |
| WO2023022141A1 (fr) | Agent thérapeutique contre le cancer | |
| AU2017201356B2 (en) | Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy | |
| CN117794579A (zh) | 癌治疗剂 | |
| TW202317196A (zh) | 用於藥物遞送應用之基於兩親性胜肽的自組裝奈米顆粒 | |
| GUTTERMAN et al. | MALIGNANT ME LANOMA, BREAST AND COLORECTAL CANCER |